Cited by 326Advanced Glycation End Products researchNF-κB Signaling PathwaysImmune Response and Inflammation

Requirement for p38 and p44/p42 Mitogen-Activated Protein Kinases in RAGE-Mediated Nuclear Factor-κB Transcriptional Activation and Cytokine Secretion

Open access
Yeh, Chen-Hsiung, Sturgis, Lydia, Haidacher, Joe, Zhang, Xue-Nong, Sherwood, Sidney J., Bjercke, Robert J., Juhasz, Ondrej, Crow, Michael T. +2 more·2001·Diabetes

Abstract

Advanced glycation end product (AGE) activation of the signal-transducing receptor for AGE (RAGE) has been linked to a proinflammatory phenotypic change within cells. However, the precise intracellular signaling pathways involved have not been elucidated. We demonstrate here that human serum albumin modified with Nε-(carboxymethyl)lysine (CML), a major AGE adduct that progressively accumulates with aging, diabetes, and renal failure, induced nuclear factor (NF)-κB–driven reporter gene expression in human monocytic THP-1 cells. The NF-κB response was blocked with a synthetic peptide corresponding to the putative ligand-binding domain of RAGE, with anti-RAGE antiserum, and by coexpression of truncated receptors lacking the intracellular domain. Signal transduction from RAGE to NF-κB involved the generation of reactive oxygen species, since reporter gene expression was blocked with the antioxidant N-acetyl-l-cysteine. CML-modified albumin produced rapid transient activation of tyrosine phosphorylation, extracellular signal-regulated kinase 1 and 2, and p38 mitogen-activated protein kinase (MAPK), but not c-Jun NH2-terminal kinase. RAGE-mediated NF-κB activation was suppressed by the selective p38 MAPK inhibitor SB203580 and by coexpression of a kinase-dead p38 dominant-negative mutant. Activation of NF-κB by CML-modified albumin increased secretion of proinflammatory cytokines (tumor necrosis factor-α, interleukin-1β, and monocyte chemoattractant protein-1) severalfold, and inhibition of p38 MAPK blocked these increases. These results indicate that p38 MAPK activation mediates RAGE-induced NF-κB–dependent secretion of proinflammatory cytokines and suggest that accelerated inflammation may be a consequence of cellular activation induced by this receptor.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/diabetes.50.6.1495

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • AGEs activate the ERK, JNK, p38, and PI3K pathways and promote activation of NF-κB.

    “AGEs activate the ERK, c-Jun N-terminal kinase (JNK), p38, and PI3K pathways and promote activation of NF-κB.”

    From The Vasculature in Prediabetes (2018) · cites this paper as [58]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Coligan JE, Kruisbeek AM, Margulies DH, Shevach EM, Strober W, Eds. New York, Greene Publishing and John Wiley & Sons, p. 7.1.1-7.1.7, 1996

Cited by

Sorted by citations

Authors
Yeh, C.-H., Sturgis, L., Haidacher, J., Zhang, X.-N., Sherwood, S. J., Bjercke, R. J., Juhasz, O., Crow, M. T., Tilton, R. G., & Denner, L.
Affiliations
  • Cell Biology and Apoptosis Program and the
  • Department of Immunology, Texas Biotechnology Corporation, Houston, Texas
  • Laboratory of Cardiovascular Science, National Institute on Aging, National Institutes of Health, Baltimore, Maryland
  • National Institutes of Health (US)
Venue
Diabetes
Published
2001-06-01
Volume
50
Issue
6
Pages
1495-1504
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2126160998
Cited by
326
References
65
Citations by year
2026: 1 · 2025: 4 · 2024: 6 · 2023: 5 · 2022: 11 · 2021: 15 · 2020: 8 · 2019: 5 · 2018: 4 · 2017: 14 · 2016: 11 · 2015: 13 · 2014: 7 · 2013: 29 · 2012: 15
FWCI
10.15
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
Keywords
receptor for advanced glycation end products, RAGE, p38 MAPK, ERK1/2, advanced glycation end products, reactive oxygen species, proinflammatory cytokine secretion, TNF-α, IL-1β, MCP-1, THP-1 cells, inflammation
MeSH terms
Receptor for Advanced Glycation End Products, Cell Line, Enzyme Activation, Multigene Family, Humans, Lysine, Monocytes, Phosphorylation, Protein-Tyrosine Kinases, Receptors, Immunologic, Transcription, Genetic, Tyrosine, Signal Transduction, Transcriptional Activation, Cytokines, NF-kappa B, Reactive Oxygen Species, Mitogen-Activated Protein Kinase 1, Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mitogen-Activated Protein Kinase 3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review